In the latest session, Augmedix Inc (NASDAQ: AUGX) closed at $3.43 up 0.29% from its previous closing price of $3.42. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 594245 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Augmedix Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.34. In the meantime, Its Debt-to-Equity ratio is 32.36 whereas as Long-Term Debt/Eq ratio is at 20.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on December 15, 2023, initiated with a In-line rating and assigned the stock a target price of $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 22 ’23 when Ginocchio Paul bought 10,000 shares for $4.85 per share. The transaction valued at 48,500 led to the insider holds 128,000 shares of the business.
Redmile Group, LLC bought 750,000 shares of AUGX for $3,000,000 on Nov 20 ’23. The Director now owns 16,404,017 shares after completing the transaction at $4.00 per share. On Nov 20 ’23, another insider, Redmile Group, LLC, who serves as the Director of the company, bought 750,000 shares for $4.00 each. As a result, the insider paid 3,000,000 and bolstered with 9,446,146 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUGX now has a Market Capitalization of 166.79M and an Enterprise Value of 168.82M. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.46 while its Price-to-Book (P/B) ratio in mrq is 192.91. Its current Enterprise Value per Revenue stands at 4.12 whereas that against EBITDA is -9.92.
Stock Price History:
Over the past 52 weeks, AUGX has reached a high of $6.25, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 4.6170, while the 200-Day Moving Average is calculated to be 4.8086.
Shares Statistics:
For the past three months, AUGX has traded an average of 334.77K shares per day and 269.84k over the past ten days. A total of 37.44M shares are outstanding, with a floating share count of 36.79M. Insiders hold about 10.86% of the company’s shares, while institutions hold 86.87% stake in the company. Shares short for AUGX as of Feb 29, 2024 were 717.9k with a Short Ratio of 2.14, compared to 921.63k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.48% and a Short% of Float of 2.62%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.1, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.11 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.44 and -$0.45 for the fiscal current year, implying an average EPS of -$0.44. EPS for the following year is -$0.44, with 4 analysts recommending between -$0.39 and -$0.52.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $12.46M this quarter.It ranges from a high estimate of $12.6M to a low estimate of $12.3M. As of the current estimate, Augmedix Inc’s year-ago sales were $8.75M, an estimated increase of 42.40% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $13.38M, an increase of 39.00% less than the figure of $42.40% in the same quarter last year. There is a high estimate of $13.5M for the next quarter, whereas the lowest estimate is $13.2M.
A total of 5 analysts have provided revenue estimates for AUGX’s current fiscal year. The highest revenue estimate was $44.8M, while the lowest revenue estimate was $44.5M, resulting in an average revenue estimate of $44.63M. In the same quarter a year ago, actual revenue was $30.93M, up 44.30% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $61.53M in the next fiscal year. The high estimate is $62.21M and the low estimate is $60.9M. The average revenue growth estimate for next year is up 37.90% from the average revenue estimate for this year.
